Beijing Scitop Bio-Tech Co.,Ltd.’s Net Profit Rose 2.2% in First Three Quarters of 2022

Beijing Scitop Bio-Tech Co.,Ltd. (北京科拓恒通生物技术股份有限公司) (300858.SZ) reported a net profit of 86.7 million yuan in the first three quarters of 2022, up 2.2% year-on-year.

Meanwhile, the company posted 264.1 million yuan in revenue, down 1.6% year-on-year.

At the end of the reporting period, it had 1.1 billion yuan in total assets and 74.8 million yuan in total liabilities, with a liability-to-asset ratio of 7.1%.